One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 1months
-
http://medilib.ir
- Duration of Time : 31 Day
Price : 100$- Special Price : 50$
Targeting the glucocorticoid receptor in relapsed ovarian cancer: a new pathway and standard treatment option in ovarian cancer
KOMET in the landscape of MEK inhibitor clinical trials for plexiform neurofibromas
Reinforcing resilience: confronting the consequences of global malaria aid cuts in Africa
Seeking an inclusive and just way to simplify the global health architecture
The need to strengthen the US Food and Drug Administration: US cuts threaten health care at home and abroad
Highlights 2025 photography competition: illuminating health stories in a single frame
Claw hand as a result of Mannerist convention – Author's reply
On lines, distractions, and the pursuit of positive change – Author's reply
Life expectancy disparities in the USA: the Ten Americas study – Author's reply
Relacorilant and nab-paclitaxel in patients with platinum-resistant ovarian cancer (ROSELLA): an open-label, randomised, controlled, phase 3 trial
Efficacy and safety of selumetinib in adults with neurofibromatosis type 1 and symptomatic, inoperable plexiform neurofibromas (KOMET): a multicentre, international, randomised, placebo-controlled, parallel, double-blind, phase 3 study
Estimating the potential malaria morbidity and mortality avertable by the US President's Malaria Initiative in 2025: a geospatial modelling analysis
Moving the dial on diagnostics: an update from the Lancet Commission on diagnostics
